Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Langer

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Radiology|June 1, 1990
Spondylometaphyseal dysplasia, corner fracture type: a heritable condition associated with coxa varaL O Langer, P W Brill, M B Ozonoff, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|April 1, 1975
The Kniest syndromeR S Lachman, D L Rimoin, D W Hollister, et al.
American Journal of Medical Genetics. Part A|August 25, 2004
Spondylometaphyseal dysplasia with cone-rod dystrophyBrent A Walters, Michael L Raff, James Ver Hoeve, et al.
Bioorganic & Medicinal Chemistry|April 20, 2001
Synthesis of high-specific-radioactivity 4- and 6-[18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heartO Langer, F Dollé, H Valette, et al.
American Journal of Medical Genetics|October 1, 1984
Fibrochondrogenesis: lethal, autosomal recessive chondrodysplasia with distinctive cartilage histopathologyC B Whitley, L O Langer, J Ophoven, et al.
Current Alzheimer Research|June 13, 2009
Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairmentE Dimou, J Booij, M Rodrigues, et al.
American Journal of Medical Genetics|January 1, 1983
A new short rib syndrome: report of two casesF A Beemer, L O Langer, J M Klep-de Pater, et al.
The Journal of Pediatrics|October 1, 1986
A new skeletal dysplasia: clinical, radiologic, and pathologic findingsB K Burton, T Sumner, L O Langer, et al.
American Journal of Medical Genetics|February 15, 1993
Further delineation of spondylo-meta-epiphyseal dysplasia, short limb-abnormal calcification type, with emphasis on diagnostic featuresL O Langer, B J Wolfson, C I Scott, et al.
British Journal of Cancer|May 14, 2009
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivoD Cejka, C Kuntner, M Preusser, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Radiology|June 1, 1990
Spondylometaphyseal dysplasia, corner fracture type: a heritable condition associated with coxa varaL O Langer, P W Brill, M B Ozonoff, et al.
The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine|April 1, 1975
The Kniest syndromeR S Lachman, D L Rimoin, D W Hollister, et al.
American Journal of Medical Genetics. Part A|August 25, 2004
Spondylometaphyseal dysplasia with cone-rod dystrophyBrent A Walters, Michael L Raff, James Ver Hoeve, et al.
Bioorganic & Medicinal Chemistry|April 20, 2001
Synthesis of high-specific-radioactivity 4- and 6-[18F]fluorometaraminol-PET tracers for the adrenergic nervous system of the heartO Langer, F Dollé, H Valette, et al.
American Journal of Medical Genetics|October 1, 1984
Fibrochondrogenesis: lethal, autosomal recessive chondrodysplasia with distinctive cartilage histopathologyC B Whitley, L O Langer, J Ophoven, et al.
Current Alzheimer Research|June 13, 2009
Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairmentE Dimou, J Booij, M Rodrigues, et al.
American Journal of Medical Genetics|January 1, 1983
A new short rib syndrome: report of two casesF A Beemer, L O Langer, J M Klep-de Pater, et al.
The Journal of Pediatrics|October 1, 1986
A new skeletal dysplasia: clinical, radiologic, and pathologic findingsB K Burton, T Sumner, L O Langer, et al.
American Journal of Medical Genetics|February 15, 1993
Further delineation of spondylo-meta-epiphyseal dysplasia, short limb-abnormal calcification type, with emphasis on diagnostic featuresL O Langer, B J Wolfson, C I Scott, et al.
British Journal of Cancer|May 14, 2009
FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivoD Cejka, C Kuntner, M Preusser, et al.
Pageof 20